STTK

NASD Shattuck Labs, Inc.
Sep 29, 2026 · 2:17 AM ET EOD Market Closed

$6.43 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.43, $0.05 below the day’s high of $6.48

YTD change
+76.16%
vs 20-day SMA
+0.45%
vs 200-day SMA
+11.73%

Price ranges

Previous day
$6.05 $6.39
open $6.33 close $6.07
-$0.26 (-4.11%)
Today
$5.85 $6.48
open $6.03 now $6.43
+$0.40 (+6.63%)
Past week
$5.86 $6.61
from $6.01 now $6.43
+$0.42 (+6.99%)
Past month
$5.78 $7.65
from $7.65 now $6.43
-$1.22 (-15.95%)
This year
$3.33 $8.33
from $3.65 now $6.43
+$2.78 (+76.16%)

Price & Performance

+0.47 (+7.89%) / 6M

$3.57$5.18$6.78$8.39Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 89.4% away from all-time highs of $60.52
  • STTK is up 76% since the beginning of the year
  • STTK is up 182% over the past 12 months
  • STTK is down 16% over the past 1 month
  • 6% of all STTK investors are betting against STTK

STTK reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +183.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.12
Earnings momentum -11.3% Quarterly EPS growth
Quarterly change -11.3%

Valuation

P/E ratio N/A
Enterprise value $582.1M
Beta 1.28

Balance sheet & scale

IncomeN/A
Revenue$1.0M
Cash$208.3M
Debt$2.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $645.3M

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.00 +2.66%
ARGX argenx SE Sponsored ADR $972.25 +1.33%
ONC BeOne Medicines Ltd. Sponsored ADR $367.00 +1.70%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.66 +0.07%
INCY Incyte Corporation $124.82 +0.75%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.